[1] Song Q, Yang H, Liu N, Gong L, An Z, Wang H. Development and validation of a framework for comprehensive vaccine value assessment: a modified Delphi study. Biomed Environ Sci. 2026. doi: 10.3967/bes2026.058.
[2] Gong L, Abudurusuli G, Zheng F, Xie J, Wang H. Estimating risk of measles virus transmission in countries with measles elimination status: a comparative measles seroprevalence study. Biomed Environ Sci. 2026. doi: 10.3967/bes2026.106.
[3] Xiu Y, Tang L, Wang F, et al. Effectiveness of pentavalent rotavirus vaccine: a propensity score matched test-negative design case-control study using medical big data in three provinces of China. Biomed Environ Sci, 2025; 38, 1032−1043. doi:  10.3967/bes2025.056
[4] GBD 2023 Vaccine Coverage Collaborators. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023. Lancet, 2025; 406, 235−60. doi:  10.1016/S0140-6736(25)01037-2
[5] Shattock AJ, Johnson HC, Sim SY, et al. Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization. Lancet, 2024; 403, 2307−16. doi:  10.1016/S0140-6736(24)00850-X
[6] Li X, Mukandavire C, Cucunubá ZM, et al. Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study. Lancet, 2021; 397, 398−408. doi:  10.1016/S0140-6736(20)32657-X
[7] Yan Y, Su Q, Yi Y, Shen L, Bi S. Immunogenicity evaluation of a SARS-CoV-2 BA. 2 subunit vaccine formulated with CpG 1826 plus alum dual adjuvant. Biomed Environ Sci, 2024; 37, 1409−1420. doi:  10.3967/bes2024.129
[8] Bolotin S, Osman S, Hughes SL, et al. In elimination settings, measles antibodies wane after vaccination but not after infection: a systematic review and meta-analysis. J Infect Dis, 2022; 226, 1127−39. doi:  10.1093/infdis/jiac039
[9] Trentini F, Poletti P, Merler S, et al. Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis. Lancet Infect Dis, 2017; 17, 1089−97. doi:  10.1016/S1473-3099(17)30421-8